Hsueh-Wei Chang

Dr. Hsueh-Wei Chang

Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Computational Biology and Chemistry
Verified
Journal Article
Closed access
LCLi-Yeh Chuang
Li-Yeh Chuang
HCHsueh-Wei Chang
Hsueh-Wei Chang
CTChung-Jui Tu
Chung-Jui Tu
CYCheng-Hong Yang
Cheng-Hong Yang

3 June 2013 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
JLJin-Ching Lee
Jin-Ching Lee
MHMing-Feng Hou
Ming-Feng Hou
HHHurng-Wern Huang
Hurng-Wern Huang
Fang-Rong ChangFang-Rong Chang
Fang-Rong Chang
CYChi Chen Yeh
Chi Chen Yeh
HCHsueh-Wei Chang
Hsueh-Wei Chang
For their various bioactivities, biomaterials derived from marine algae are important ingredients in many products, such as cosmetics and drugs for treating cancer and other diseases. This mini-review comprehensively compares the bioactivities and biological functions of biomaterials from red, green, brown, and blue-green algae. The anti-oxidative effects and bioactivities of several different crude extracts of algae have been evaluated both in vitro a nd in vivo. Natural products derived from marine algae protect cells by modulating the effects of oxidative stress. Because oxidative stress plays important roles in inflammatory reactions and in carcinogenesis, marine algal natural products have potential for use in anti-cancer and anti-inflammatory drugs.


1 April 2016 in Cancer Letters
Verified
Journal Article
Closed access
CYChing-Yu Yen
Ching-Yu Yen
HHHurng-Wern Huang
Hurng-Wern Huang
CSChih-Wen Shu
Chih-Wen Shu
MHMing-Feng Hou
Ming-Feng Hou
Shyng-Shiou YuanShyng-Shiou Yuan
Shyng-Shiou Yuan
HCHsueh-Wei Chang
Hsueh-Wei Chang

19 July 2015 in Tumor Biology
Verified
Journal Article
Open access
PDF file
AFAmmad Farooqi
Ammad Farooqi
KLKun-Tzu Li
Kun-Tzu Li
SFSundas Fayyaz
Sundas Fayyaz
YCYung-Ting Chang
Yung-Ting Chang
MIMuhammad Ismail
Muhammad Ismail
HCHsueh-Wei Chang
Hsueh-Wei Chang
Prior research has demonstrated how the endoplasmic reticulum (ER) functions as a multifunctional organelle and as a well-orchestrated protein-folding unit. It consists of sensors which detect stress-induced unfolded/misfolded proteins and it is the place where protein folding is catalyzed with chaperones. During this folding process, an immaculate disulfide bond formation requires an oxidized environment provided by the ER. Protein folding and the generation of reactive oxygen species (ROS) as a protein oxidative byproduct in ER are crosslinked. An ER stress-induced response also mediates the expression of the apoptosis-associated gene C/EBP-homologous protein (CHOP) and death receptor 5 (DR5). ER stress induces the upregulation of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) receptor and opening new horizons for therapeutic research. These findings can be used to maximize TRAIL-induced apoptosis in xenografted mice. This review summarizes the current understanding of the interplay between ER stress and ROS. We also discuss how damage-associated molecular patterns (DAMPs) function as modulators of immunogenic cell death and how natural products and drugs have shown potential in regulating ER stress and ROS in different cancer cell lines. Drugs as inducers and inhibitors of ROS modulation may respectively exert inducible and inhibitory effects on ER stress and unfolded protein response (UPR). Reconceptualization of the molecular crosstalk among ROS modulating effectors, ER stress, and DAMPs will lead to advances in anticancer therapy.

1 December 2010 in Process Biochemistry
Verified
Journal Article
Closed access
Hui-Min David WangHui-Min David Wang
Hui-Min David Wang
JPJian-Liang Pan
Jian-Liang Pan
CCChun-Yen Chen
Chun-Yen Chen
CCChien-Chich Chiu
Chien-Chich Chiu
MYMu-Hoe Yang
Mu-Hoe Yang
JCJo-Shu Chang
Jo-Shu Chang